Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

1.

TAK-779, a nonpeptide CC chemokine receptor antagonist, protects the brain against focal cerebral ischemia in mice.

Takami S, Minami M, Katayama T, Nagata I, Namura S, Satoh M.

J Cereb Blood Flow Metab. 2002 Jul;22(7):780-4.

PMID:
12142563
[PubMed - indexed for MEDLINE]
Free Article
2.

Chemokine receptor antagonist peptide, viral MIP-II, protects the brain against focal cerebral ischemia in mice.

Takami S, Minami M, Nagata I, Namura S, Satoh M.

J Cereb Blood Flow Metab. 2001 Dec;21(12):1430-5.

PMID:
11740204
[PubMed - indexed for MEDLINE]
Free Article
3.

Chemokine receptor blockade with a synthetic nonpeptide compound attenuates cardiac allograft vasculopathy.

Bastani S, Sherman W, Schnickel GT, Hsieh GR, Bhatia R, Fishbein MC, Ardehali A.

Transplantation. 2009 Oct 27;88(8):995-1001. doi: 10.1097/TP.0b013e3181b9ccd5.

PMID:
19855245
[PubMed - indexed for MEDLINE]
4.

The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3.

Gao P, Zhou XY, Yashiro-Ohtani Y, Yang YF, Sugimoto N, Ono S, Nakanishi T, Obika S, Imanishi T, Egawa T, Nagasawa T, Fujiwara H, Hamaoka T.

J Leukoc Biol. 2003 Feb;73(2):273-80.

PMID:
12554804
[PubMed - indexed for MEDLINE]
Free Article
5.

HIV entry inhibitor TAK-779 attenuates atherogenesis in low-density lipoprotein receptor-deficient mice.

van Wanrooij EJ, Happé H, Hauer AD, de Vos P, Imanishi T, Fujiwara H, van Berkel TJ, Kuiper J.

Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2642-7. Epub 2005 Oct 20.

PMID:
16239591
[PubMed - indexed for MEDLINE]
Free Article
6.

The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis.

Tokuyama H, Ueha S, Kurachi M, Matsushima K, Moriyasu F, Blumberg RS, Kakimi K.

Int Immunol. 2005 Aug;17(8):1023-34. Epub 2005 Jul 6.

PMID:
16000328
[PubMed - indexed for MEDLINE]
Free Article
7.

VEGF protects brain against focal ischemia without increasing blood--brain permeability when administered intracerebroventricularly.

Kaya D, Gürsoy-Ozdemir Y, Yemisci M, Tuncer N, Aktan S, Dalkara T.

J Cereb Blood Flow Metab. 2005 Sep;25(9):1111-8. Erratum in: J Cereb Blood Flow Metab. 2006 Mar;26(3):447.

PMID:
15829918
[PubMed - indexed for MEDLINE]
8.

A novel CCR5/CXCR3 antagonist protects intestinal ischemia/reperfusion injury.

Akahori T, Sho M, Kashizuka H, Nomi T, Kanehiro H, Nakajima Y.

Transplant Proc. 2006 Dec;38(10):3366-8.

PMID:
17175273
[PubMed - indexed for MEDLINE]
10.

Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model.

Pei Z, Pang SF, Cheung RT.

Stroke. 2003 Mar;34(3):770-5. Epub 2003 Feb 6.

PMID:
12624306
[PubMed - indexed for MEDLINE]
Free Article
11.

Effects of midazolam on brain injury after transient focal cerebral ischemia in rats*.

Lei B, Popp S, Cottrell JE, Kass IS.

J Neurosurg Anesthesiol. 2009 Apr;21(2):131-9. doi: 10.1097/ANA.0b013e318191697a.

PMID:
19295392
[PubMed - indexed for MEDLINE]
12.

In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke.

Petty MA, Neumann-Haefelin C, Kalisch J, Sarhan S, Wettstein JG, Juretschke HP.

Eur J Pharmacol. 2003 Aug 1;474(1):53-62.

PMID:
12909195
[PubMed - indexed for MEDLINE]
13.

Inhibition of MEK/ERK 1/2 pathway reduces pro-inflammatory cytokine interleukin-1 expression in focal cerebral ischemia.

Wang ZQ, Wu DC, Huang FP, Yang GY.

Brain Res. 2004 Jan 16;996(1):55-66.

PMID:
14670631
[PubMed - indexed for MEDLINE]
14.

Intravenous administration of thioredoxin decreases brain damage following transient focal cerebral ischemia in mice.

Hattori I, Takagi Y, Nakamura H, Nozaki K, Bai J, Kondo N, Sugino T, Nishimura M, Hashimoto N, Yodoi J.

Antioxid Redox Signal. 2004 Feb;6(1):81-7.

PMID:
14713338
[PubMed - indexed for MEDLINE]
15.

Effects of Anemarrhena asphodeloides on focal ischemic brain injury induced by middle cerebral artery occlusion in rats.

Oh JK, Hyun SY, Oh HR, Jung JW, Park C, Lee SY, Park JH, Kim SY, Kim KH, Kim YK, Ryu JH.

Biol Pharm Bull. 2007 Jan;30(1):38-43.

PMID:
17202656
[PubMed - indexed for MEDLINE]
Free Article
16.

TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans.

Baba M, Takashima K, Miyake H, Kanzaki N, Teshima K, Wang X, Shiraishi M, Iizawa Y.

Antimicrob Agents Chemother. 2005 Nov;49(11):4584-91.

PMID:
16251299
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion.

Sayeed I, Guo Q, Hoffman SW, Stein DG.

Ann Emerg Med. 2006 Apr;47(4):381-9. Epub 2006 Feb 21.

PMID:
16546625
[PubMed - indexed for MEDLINE]
18.

Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.

Luo Y, Yin W, Signore AP, Zhang F, Hong Z, Wang S, Graham SH, Chen J.

J Neurochem. 2006 Apr;97(2):435-48. Epub 2006 Mar 15.

PMID:
16539667
[PubMed - indexed for MEDLINE]
19.

Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia.

Vakili A, Kataoka H, Plesnila N.

J Cereb Blood Flow Metab. 2005 Aug;25(8):1012-9.

PMID:
15744246
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk